Family · Pharmaceutical analytical standards
Rizatriptan
A triptan, a selective agonist of the serotonin 5-HT1B and 5-HT1D receptors, approved in the United States in June 1998 for the acute treatment of migraine attacks, with or without aura. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?It was the fourth triptan approved in the United States; it also comes as freeze-dried tablets that dissolve on the tongue within seconds, with no need for water.
No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
